National Comprehensive Cancer Network



About NCCN

Ovarian Cancer Panel - Disclosures as of 7/20/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ronald D. Alvarez, MD

None

Eli Lilly and Company;
GlaxoSmithKline;
Ortho Biotech Products, L.P.

None

None

7/13/2012

Deborah K. Armstrong, MD

None

Abraxis Bioscience, Inc.;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Morphotek Inc.

None

None

6/28/2012

Barry Boston, MD

None

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

10/19/2011

Robert Burger, MD, FACOG, FACS

None

None

None

None

3/22/2013

Lee-may Chen, MD

None

None

None

None

4/11/2013

Larry Copeland, MD

None

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

3/9/2013

Marta Ann Crispens, MD

None

None

None

None

5/5/2011

Mary Dwyer, MS

None

None

None

None

3/26/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

David M. Gershenson, MD

None

National Cancer Institute

Abbott Laboratories;
Amgen Inc.;
Eli Lilly and Company;
Johnson & Johnson;
Elsevier

None

8/22/2012

Heidi J. Gray, MD

None

None

None

None

4/24/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Perry W. Grigsby, MD, MS, MBA

None

None

None

None

7/1/2009

Ardeshir Hakam, MD

None

None

None

None

3/7/2013

Laura J. Havrilesky, MD

None

BD-TriPath Oncology;
Precision Therapeutics, Inc.

None

None

4/3/2012

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

4/10/2013

Carolyn Johnston, MD

None

None

None

american cancer society-great lakes division;
michigan cancer consortium

8/19/2012

Shashikant Lele, MD

None

None

None

None

4/24/2013

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.

Eisai Inc.;
Merck & Co., Inc.

None

None

7/3/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Robert J. Morgan, MD, FACP

NIH-CTEP

None

Abbott Laboratories

None

3/12/2013

David M. O'Malley, MD

Genentech, Inc.

KCI

None

None

3/20/2013

Richard T. Penson, MD, MRCP

None

None

None

None

3/7/2013

Steven W. Remmenga, MD

None

None

None

None

5/6/2013

Paul Sabbatini, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Johnson & Johnson

None

None

8/16/2012

Russell J. Schilder, MD

None

None

None

None

11/5/2010

Julian C. Schink, MD

None

None

None

None

3/8/2013

Nelson Teng, MD, PhD

GOG

None

None

None

3/5/2013

Theresa L. Werner, MD

None

None

None

None

4/10/2013

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved